Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

BACKGROUND: Patients with gene expression profiling-defined high-risk myeloma in relapse have poor outcomes with current therapies. We tested whether natural killer cells expanded by co-culture with K562 cells transfected with 41BBL and membrane-bound interleukin-15 could kill myeloma cells with a h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garg, Tarun K., Szmania, Susann M., Khan, Junaid A., Hoering, Antje, Malbrough, Paul A., Moreno-Bost, Amberly, Greenway, Amy D., Lingo, Joshuah D., Li, Xin, Yaccoby, Shmuel, Suva, Larry J., Storrie, Brian, Tricot, Guido, Campana, Dario, Shaughnessy, John D., Nair, Bijay P., Bellamy, William T., Epstein, Joshua, Barlogie, Bart, van Rhee, Frits
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2012
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3436235/
https://ncbi.nlm.nih.gov/pubmed/22419581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.056747
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados